Barrington Research Analysts Boost Earnings Estimates for Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Barrington Research raised their Q3 2017 earnings estimates for Henry Schein in a research note issued to investors on Wednesday. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $1.79 for the quarter, up from their prior forecast of $1.78. Barrington Research has a “Outperform” rating and a $198.00 price objective on the stock. Barrington Research also issued estimates for Henry Schein’s Q1 2018 earnings at $1.87 EPS, Q2 2018 earnings at $1.94 EPS, Q4 2018 earnings at $2.22 EPS, FY2018 earnings at $8.00 EPS and FY2019 earnings at $8.80 EPS.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.64 earnings per share.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/2801236/barrington-research-analysts-boost-earnings-estimates-for-henry-schein-inc-nasdaqhsic.html.

Other analysts have also issued research reports about the company. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Tuesday, April 25th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 target price on the stock in a research note on Monday. Jefferies Group LLC reiterated a “hold” rating and issued a $177.00 target price on shares of Henry Schein in a research note on Friday, July 21st. Credit Suisse Group reiterated a “hold” rating and issued a $160.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. Finally, Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $185.56.

Shares of Henry Schein (HSIC) opened at 167.32 on Friday. The company has a market cap of $13.25 billion, a PE ratio of 24.45 and a beta of 1.09. Henry Schein has a 12-month low of $146.23 and a 12-month high of $186.99. The company has a 50-day moving average of $181.94 and a 200 day moving average of $175.01.

Institutional investors have recently bought and sold shares of the company. Eads & Heald Investment Counsel increased its position in Henry Schein by 0.5% in the second quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock worth $274,000 after buying an additional 8 shares during the last quarter. Girard Partners LTD. increased its position in Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock worth $529,000 after buying an additional 10 shares during the last quarter. Cleararc Capital Inc. increased its position in Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock worth $331,000 after buying an additional 11 shares during the last quarter. Intrust Bank NA increased its position in Henry Schein by 1.1% in the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after buying an additional 13 shares during the last quarter. Finally, Penserra Capital Management LLC increased its position in Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock worth $258,000 after buying an additional 15 shares during the last quarter. 90.87% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.